Guenter Linz
42Patents
14h-index
56Co-inventors
84Inventor score
Filing activity: Mar 11, 1992 → May 21, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5463071A | 5-membered heterocyclic compounds, processes for preparing them and pharmaceutical compositions containing these compounds | Chemistry; Metallurgy | 85 | Expired |
| US5434150A | Condensed 5-membered heterocyclic compounds, processes for preparing them and pharmaceutical preparations containing these compounds | Chemistry; Metallurgy | 70 | Expired |
| US5541343A | Cyclic imino derivatives and pharmaceutical compositions containing them | Chemistry; Metallurgy | 64 | Expired |
| US5276049A | Cyclic urea derivatives, pharmaceutical compositions containing these compounds and methods of using the same | Chemistry; Metallurgy | 52 | Expired |
| US7238807B2 | Process for the manufacture of fused piperazin-2-one derivatives | Human Necessities | 36 | Expired |
| US5455348A | 2-pyrrolidinones, pharmaceutical compositions containing these compounds and processes for preparing them | Chemistry; Metallurgy | 31 | Expired |
| US7439358B2 | Specific salt, anhydrous and crystalline form of a dihydropteridione derivative | Human Necessities | 27 | Active |
| US5418233A | Heterobiarly derivatives and pharmaceutical compositions thereof | Chemistry; Metallurgy | 26 | Expired |
| US5591769A | Cyclic imino derivatives and pharmaceutical compositions containing them | Chemistry; Metallurgy | 25 | Expired |
| US7626019B2 | Intermediate compounds for the manufacture of fused piperazin-2-one derivatives | Human Necessities | 25 | Active |
| US7728134B2 | Hydrates and polymorphs of 4[[(7R)-8-cyclopentyl-7-ethyl-5,6,7,8-tetrahydro-5-methyl-6-oxo-2-pteridinyl]amino]-3-methoxy-N-(1-methyl-4-piperidinyl)-benzamide, process for their manufacture and their use as medicament | Chemistry; Metallurgy | 19 | Expired |
| US7119093B2 | 3-Z-[1-(4-(N-((4-Methyl-piperazin-1-yl)-methylcarbonyl)-N-methyl-amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone-monoethanesulphonate and the use thereof as a pharmaceutical composition | Human Necessities | 19 | Expired |
| US6919325B2 | Pharmaceutical compositions containing tiotropium salts and low-solubility salmeterol salts | Human Necessities | 18 | Expired |
| US7759485B2 | Process for the manufacture of dihydropteridinones | Chemistry; Metallurgy | 18 | Active |
| US5478942A | Cyclic urea derivatives and pharmaceutical compositions containing these compounds | Chemistry; Metallurgy | 12 | Expired |
| US6680345B2 | Salicylic acid salts of salmeterol | Chemistry; Metallurgy | 12 | Expired |
| US5852192A | Cyclic urea derivatives, pharmaceutical compositions containing these compounds and processes for preparing them | Chemistry; Metallurgy | 12 | Expired |
| US6756508B2 | Cinnamic acid salts, processes for their preparation, and their use as medicaments | Human Necessities | 11 | Expired |
| US8034816B2 | Hydrates and polymorphs of 4-[[(7R)-8-cyclopentyl-7-ethyl-5,6,7,8-tetrahydro-5-methyl-6-oxo-2-pteridinyl]amino]-3-methoxy-N-(1-methyl-4-piperidinyl)-benzamide, process for their manufacture and their use as medicament | Chemistry; Metallurgy | 9 | Active |
| US8138373B2 | Process for the manufacture of dihydropteridinones | Chemistry; Metallurgy | 9 | Active |
| US8138341B2 | Intermediate compounds useful for the manufacture of dihydropteridinones | Chemistry; Metallurgy | 9 | Active |
| US5563268A | Heterobiaryl derivatives | Chemistry; Metallurgy | 8 | Expired |
| US8202867B2 | Methods of using hydrates and polymorphs of 4-[[(7R)-8-cyclopentyl-7-ethyl-5,6,7,8-tetrahydro-5-methyl-6-oxo-2-pteridinyl]amino]-3-methoxy-N-(1-methyl-4-piperidinyl)-benzamide | Chemistry; Metallurgy | 8 | Active |
| US8188086B2 | Specific salt, anhydrous and crystalline form of a dihydropteridione derivative | Human Necessities | 8 | Active |
| US5489693A | Cyclic imino derivatives, pharmaceutical compositions containing these compounds and processes preparing them | Chemistry; Metallurgy | 7 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.